Prime Medicine, Inc.
PRME
$1.24
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 190.44M | 175.53M | 162.87M | 210.72M | 121.67M |
| Total Receivables | -- | 55.00M | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.78M | 6.01M | 4.20M | 4.20M | 19.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 14.67M | 9.54M | 3.74M | 2.73M | 2.25M |
| Total Current Assets | 211.89M | 246.07M | 170.80M | 217.65M | 142.98M |
|
|
|||||
| Total Current Assets | 211.89M | 246.07M | 170.80M | 217.65M | 142.98M |
| Net Property, Plant & Equipment | 71.56M | 72.65M | 75.41M | 79.45M | 36.60M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.06M | 14.06M | 13.50M | 14.28M | 14.28M |
| Total Assets | 297.51M | 332.78M | 259.71M | 311.38M | 193.85M |
|
|
|||||
| Total Accounts Payable | 11.35M | 5.43M | 4.64M | 10.08M | 19.54M |
| Total Accrued Expenses | 11.82M | 17.28M | 8.82M | 4.20M | 10.23M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.61M | 4.48M | 5.22M | 6.75M | 9.28M |
| Total Finance Division Other Current Liabilities | 11.18M | 10.68M | 2.07M | 3.41M | 17.38M |
| Total Other Current Liabilities | 11.18M | 10.68M | 2.07M | 3.41M | 17.38M |
| Total Current Liabilities | 37.96M | 37.88M | 20.75M | 24.44M | 56.42M |
|
|
|||||
| Total Current Liabilities | 37.96M | 37.88M | 20.75M | 24.44M | 56.42M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 37.18M | 36.76M | 36.37M | 37.04M | 4.36M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 69.22M | 68.64M | 6.00M | 6.13M | -- |
| Total Liabilities | 144.36M | 143.28M | 63.12M | 67.62M | 60.78M |
|
|
|||||
| Common Stock & APIC | 840.36M | 834.42M | 789.08M | 780.95M | 624.42M |
| Retained Earnings | -687.21M | -644.94M | -592.42M | -537.09M | -491.33M |
| Treasury Stock & Other | 1.00K | 21.00K | -71.00K | -95.00K | -15.00K |
| Total Common Equity | 153.15M | 189.50M | 196.59M | 243.77M | 133.07M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 153.15M | 189.50M | 196.59M | 243.77M | 133.07M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 153.15M | 189.50M | 196.59M | 243.77M | 133.07M |
|
|
|||||